Richard Henriques

Nativis Inc. has announced that Richard Henriques has been appointed to the company’s board of directors.

Henriques is an experienced financial executive with an extensive background in the large-capitalization pharmaceutical, early-stage biotechnology and nonprofit industries. He served as Chief Financial Officer of the Bill & Melinda Gates Foundation from 2010 to 2014. During his tenure, Henriques helped guide the foundation through a critical growth phase. His efforts helped redesign the financial structure of the organization, close a $100 million global healthcare investment fund, and build the new leadership team, all of which have been critical to the foundation’s success. Prior to joining the Bill & Melinda Gates Foundation, Henriques spent 27 years at Merck & Company where he served in key financial positions including Senior Vice President of Finance, and Vice President and Corporate Controller. He managed all aspects of Merck’s financial operations for a new $20 billion division and was also responsible for the company’s financial planning and reporting.

Nativis Inc. is a clinical-stage life science bioelectronics company developing noninvasive, safe and highly effective treatments for cancers and other serious diseases. Henriques’ appointment to the board is effective immediately.